{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:08:45Z","timestamp":1793286525245,"version":"4.5.0"},"reference-count":135,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","award":["32339"],"award-info":[{"award-number":["32339"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ejmech.2024.116279","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T11:30:40Z","timestamp":1709206240000},"page":"116279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Novel thiazolidin-4-one benzenesulfonamide hybrids as PPAR\u03b3 agonists: Design, synthesis and in vivo anti-diabetic evaluation"],"prefix":"10.1016","volume":"269","author":[{"given":"Islam H.","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha M.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"El Kerdawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud T.","family":"Abo-Elfadl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba M.I.","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Sciandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3176-0187","authenticated-orcid":false,"given":"Iman A.Y.","family":"Ghannam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116279_bib1","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/347645a0","article-title":"Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators","volume":"347","author":"Issemann","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.116279_bib2","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.1021\/acs.jmedchem.0c00048","article-title":"Insights into PPAR\u03b3 phosphorylation and its inhibition mechanism","volume":"63","author":"Montanari","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202100399","article-title":"Design and synthesis of novel quinazolinone-based fibrates as PPARalpha agonists with antihyperlipidemic activity","volume":"355","author":"Hassan","year":"2022","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2024.116279_bib4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.biochem.77.061307.091829","article-title":"Fat and beyond: the diverse biology of PPARgamma","volume":"77","author":"Tontonoz","year":"2008","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2024.116279_bib5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","article-title":"The mechanisms of action of PPARs","volume":"53","author":"Berger","year":"2002","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ejmech.2024.116279_bib6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.tips.2005.03.003","article-title":"PPARs: therapeutic targets for metabolic disease","volume":"26","author":"Berger","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2024.116279_bib7","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/jm990554g","article-title":"The PPARs: from orphan receptors to drug discovery","volume":"43","author":"Willson","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib8","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/47254","article-title":"Dominant negative mutations in human PPAR\u03b3 associated with severe insulin resistance, diabetes mellitus and hypertension","volume":"402","author":"Barroso","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.116279_bib9","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature09291","article-title":"Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPAR\u03b3 by Cdk 5","volume":"466","author":"Choi","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.116279_bib10","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ejmech.2016.12.020","article-title":"Thiazolidinediones and PPAR orchestra as antidiabetic agents: from past to present","volume":"126","author":"Yasmin","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib11","article-title":"Trends in antidiabetic drug discovery: FDA approved drugs, new drugs in clinical trials and global sales","volume":"12","author":"Dahl\u00e9n","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116279_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113653","article-title":"Identification of a novel PPAR\u03b3 modulator with good anti-diabetic therapeutic index via structure-based screening, optimization and biological validation","volume":"154","author":"Chen","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2024.116279_bib13","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/cbdd.14020","article-title":"A new insight into the treatment of diabetes by means of pan PPAR agonists","volume":"100","author":"Chandra","year":"2022","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2024.116279_bib14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4274\/tjps.galenos.2021.70105","article-title":"Peroxisome proliferator-activated receptors as superior targets for treating diabetic disease, design strategies - review article","volume":"19","author":"Qaoud","year":"2022","journal-title":"Turk J Pharm Sci"},{"key":"10.1016\/j.ejmech.2024.116279_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2019.115263","article-title":"Anti-diabetic drugs recent approaches and advancements","volume":"28","author":"Dowarah","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bioorg.2017.11.010","article-title":"Design, synthesis and molecular docking of thiazolidinedione based benzene sulphonamide derivatives containing pyrazole core as potential anti-diabetic agents","volume":"76","author":"Naim","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib17","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4093\/dmj.2020.0272","article-title":"Lobeglitazone: a novel thiazolidinedione for the management of type 2 diabetes mellitus","volume":"45","author":"Bae","year":"2021","journal-title":"Diabetes Metab. J"},{"key":"10.1016\/j.ejmech.2024.116279_bib18","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.clinthera.2015.06.009","article-title":"Pharmacokinetic interaction between amlodipine and lobeglitazone, a novel peroxisome proliferator-activated receptor-\u03b3 agonist, in healthy subjects","volume":"37","author":"Kim","year":"2015","journal-title":"Clin. Therapeut."},{"key":"10.1016\/j.ejmech.2024.116279_bib19","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/cbdd.12806","article-title":"Multitargeted bioactive ligands for PPARs discovered in the last decade","volume":"88","author":"Zhang","year":"2016","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2024.116279_bib20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1517\/14656566.9.3.405","article-title":"Clinical trials with thiazolidinediones in subjects with Type 2 diabetes--is pioglitazone any different from rosiglitazone?","volume":"9","author":"Doggrell","year":"2008","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.ejmech.2024.116279_bib21","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.3390\/pharmaceutics14102139","article-title":"Development of heterocyclic PPAR ligands for potential therapeutic applications","volume":"14","author":"Virendra","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2024.116279_bib22","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1248\/bpb.34.1094","article-title":"Pharmacology and in vitro profiling of a novel peroxisome proliferator-activated receptor \u03b3 ligand, Cerco-A","volume":"34","author":"Wakabayashi","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2024.116279_bib23","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.str.2007.07.014","article-title":"Partial agonists activate PPAR\u03b3 using a helix 12 independent mechanism","volume":"15","author":"Bruning","year":"2007","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2024.116279_bib24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1021\/acschembio.5b00580","article-title":"SR2067 reveals a unique kinetic and structural signature for PPAR\u03b3 partial agonism","volume":"11","author":"van Marrewijk","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.116279_bib25","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.3390\/ijms19082189","article-title":"The opportunities and challenges of peroxisome proliferator-activated receptors ligands in clinical drug discovery and development","volume":"19","author":"Hong","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116279_bib26","doi-asserted-by":"crossref","DOI":"10.1155\/2008\/936906","article-title":"The development of INT131 as a selective PPARgamma modulator: approach to a safer insulin sensitizer","volume":"2008","author":"Higgins","year":"2008","journal-title":"PPAR Res."},{"key":"10.1016\/j.ejmech.2024.116279_bib27","doi-asserted-by":"crossref","first-page":"10335","DOI":"10.1021\/acs.jmedchem.6b01340","article-title":"Probing the complex binding modes of the PPAR\u03b3 partial agonist 2-chloro-N-(3-chloro-4-((5-chlorobenzo[d]thiazol-2-yl)thio)phenyl)-4-(trifluoromethyl)benzenesulfonamide (T2384) to orthosteric and allosteric sites with NMR spectroscopy","volume":"59","author":"Hughes","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib28","doi-asserted-by":"crossref","first-page":"9168","DOI":"10.1074\/jbc.M800104200","article-title":"T2384, a novel antidiabetic agent with unique peroxisome proliferator-activated receptor gamma binding properties","volume":"283","author":"Li","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib29","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1021\/acs.jmedchem.6b01727","article-title":"Structure\u2013activity relationship of 2,4-dichloro-N-(3,5-dichloro-4-(quinolin-3-yloxy)phenyl)benzenesulfonamide (INT131) analogs for ppar\u03b3-targeted antidiabetics","volume":"60","author":"Frkic","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ejmech.2012.10.027","article-title":"Synthesis of N-(5-chloro-6-(quinolin-3-yloxy)pyridin-3-yl)benzenesulfonamide derivatives as non-TZD peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) agonist","volume":"58","author":"Bajare","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib31","doi-asserted-by":"crossref","first-page":"17259","DOI":"10.1021\/acs.jmedchem.1c01331","article-title":"Structure-based design of dual partial peroxisome proliferator-activated receptor \u03b3 agonists\/soluble epoxide hydrolase inhibitors","volume":"64","author":"Lillich","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.826811","article-title":"The role of peroxisome proliferator-activated receptor gamma and atherosclerosis: post-translational modification and selective modulators","volume":"13","author":"Yin","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ejmech.2024.116279_bib33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.phrs.2015.12.010","article-title":"New PPAR\u03b3 partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr(-\/-) mice","volume":"104","author":"Silva","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2024.116279_bib34","doi-asserted-by":"crossref","first-page":"28169","DOI":"10.1074\/jbc.M111.332106","article-title":"GQ-16, a novel peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) ligand, promotes insulin sensitization without weight gain","volume":"287","author":"Amato","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105883","article-title":"Design, synthesis and anticancer activity of novel 2-arylbenzimidazole\/2-thiopyrimidines and 2-thioquinazolin-4(3H)-ones conjugates as targeted RAF and VEGFR-2 kinases inhibitors","volume":"126","author":"Ali","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200341","article-title":"Novel 2-oxo-2-phenylethoxy and benzyloxy diaryl urea hybrids as VEGFR-2 inhibitors: design, synthesis, and anticancer evaluation","volume":"356","author":"Ghannam","year":"2023","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2024.116279_bib37","first-page":"1157","article-title":"Imidazo[4,5-b]phenazines as dual topoisomerase I\/II\u03b1 inhibitors: design, synthesis, biological evaluation and molecular docking","volume":"65","author":"Ghannam","year":"2022","journal-title":"Egypt. J. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105045","article-title":"Design, synthesis and anticancer evaluation of novel 1,3-benzodioxoles and 1,4-benzodioxines","volume":"139","author":"Hassan","year":"2019","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2024.116279_bib39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00044-023-03166-z","article-title":"Design and synthesis of novel cycloalkanecarboxamide parabanic acid hybrids as anticonvulsants","volume":"33","author":"Abd-Allah","year":"2024","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2024.116279_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105170","article-title":"Discovery of 4-benzyloxy and 4-(2-phenylethoxy) chalcone fibrate hybrids as novel PPARalpha agonists with anti-hyperlipidemic and antioxidant activities: design, synthesis and in vitro\/in vivo biological evaluation","volume":"115","author":"Hassan","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201700299","article-title":"Design, synthesis, and molecular docking of novel indole scaffold-based VEGFR-2 inhibitors as targeted anticancer agents","volume":"351","author":"Roaiah","year":"2018","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2024.116279_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14776-0","article-title":"Novel benzylidene thiazolidinedione derivatives as partial PPAR\u03b3 agonists and their antidiabetic effects on type 2 diabetes","volume":"7","author":"Yasmin","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116279_bib43","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11892-008-0031-0","article-title":"Beta-cell failure in type 2 diabetes mellitus","volume":"8","author":"Lencioni","year":"2008","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.ejmech.2024.116279_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115948","article-title":"Discovery of triazole tethered thymol\/carvacrol-coumarin hybrids as new class of \u03b1-glucosidase inhibitors with potent in vivo antihyperglycemic activities","volume":"263","author":"Singh","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib45","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3390\/jcm3030923","article-title":"Importance of beta cell function for the treatment of type 2 diabetes","volume":"3","author":"Saisho","year":"2014","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ejmech.2024.116279_bib46","series-title":"Test No. 425: Acute Oral Toxicity: Up-And-Down Procedure","year":"2001"},{"key":"10.1016\/j.ejmech.2024.116279_bib47","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3390\/biom12091225","article-title":"The nicotinamide\/streptozotocin rodent model of type 2 diabetes: renal pathophysiology and redox imbalance features","volume":"12","author":"Yan","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2024.116279_bib48","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12902-021-00795-6","article-title":"Nicotinamide attenuates streptozotocin-induced diabetes complications and increases survival rate in rats: role of autonomic nervous system","volume":"21","author":"Cruz","year":"2021","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.ejmech.2024.116279_bib49","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1258\/ebm.2012.011372","article-title":"Streptozotocin-nicotinamide-induced diabetes in the rat. Characteristics of the experimental model","volume":"237","author":"Szkudelski","year":"2012","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.ejmech.2024.116279_bib50","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9276343","article-title":"Antihyperglycemic effects and mode of actions of musa paradisiaca leaf and fruit peel hydroethanolic extracts in nicotinamide\/streptozotocin-induced diabetic rats","volume":"2020","author":"Abdel Aziz","year":"2020","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.ejmech.2024.116279_bib51","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1089\/jmf.2006.9.562","article-title":"Antihyperglycemic effect of umbelliferone in streptozotocin-diabetic rats","volume":"9","author":"Ramesh","year":"2006","journal-title":"J. Med. Food"},{"key":"10.1016\/j.ejmech.2024.116279_bib52","series-title":"Harper's Illustrated Biochemistry, 31e","first-page":"167","article-title":"Gluconeogenesis & the control of blood glucose","author":"Bender","year":"2006"},{"key":"10.1016\/j.ejmech.2024.116279_bib53","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/vms3.389","article-title":"Musa paradisiaca L. leaf and fruit peel hydroethanolic extracts improved the lipid profile, glycemic index and oxidative stress in nicotinamide\/streptozotocin-induced diabetic rats","volume":"7","author":"Ahmed","year":"2021","journal-title":"Vet. Med. Sci."},{"key":"10.1016\/j.ejmech.2024.116279_bib54","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s13300-017-0265-4","article-title":"A practical review of C-peptide testing in diabetes","volume":"8","author":"Leighton","year":"2017","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.ejmech.2024.116279_bib55","doi-asserted-by":"crossref","first-page":"634","DOI":"10.5603\/EP.a2021.0084","article-title":"Neu-P11 - a novel melatonin receptor agonist, could improve the features of type-2 diabetes mellitus in rats","volume":"72","author":"Li","year":"2021","journal-title":"Endokrynol. Pol."},{"key":"10.1016\/j.ejmech.2024.116279_bib56","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1210\/jcem-68-2-374","article-title":"Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies","volume":"68","author":"Bonora","year":"1989","journal-title":"J. Clin. Endocrinol."},{"key":"10.1016\/j.ejmech.2024.116279_bib57","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1301\/nr.2003.dec.397-412","article-title":"Evaluation of insulin sensitivity in clinical practice and in research settings","volume":"61","author":"Monzillo","year":"2003","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.ejmech.2024.116279_bib58","doi-asserted-by":"crossref","first-page":"42351","DOI":"10.1074\/jbc.R400019200","article-title":"Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes","volume":"279","author":"Robertson","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib59","first-page":"78","article-title":"Antidiabetic and antihyperlipidemic activity of Euphorbia thymifolia L. extracts on streptozotocin-nicotinamide induced type 2 diabetic rats","volume":"7","author":"Parmar","year":"2017","journal-title":"App Pharm Sci"},{"key":"10.1016\/j.ejmech.2024.116279_bib60","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1730492","article-title":"Antidiabetic potency, antioxidant effects, and mode of actions of Citrus reticulata fruit peel hydroethanolic extract, hesperidin, and quercetin in nicotinamide\/streptozotocin-induced wistar diabetic rats","volume":"2020","author":"Ali","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejmech.2024.116279_bib61","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1053\/j.ackd.2017.12.005","article-title":"Acute kidney injury and progression of diabetic kidney disease","volume":"25","author":"Yu","year":"2018","journal-title":"Adv. Chron. Kidney Dis."},{"key":"10.1016\/j.ejmech.2024.116279_bib62","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00592-010-0249-6","article-title":"Association between serum C-peptide levels and chronic microvascular complications in Korean type 2 diabetic patients","volume":"49","author":"Kim","year":"2012","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.ejmech.2024.116279_bib63","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/dmrr.1071","article-title":"Proinsulin C-peptide prevents type-1 diabetes-induced decrease of renal Na+-K+-ATPase \u03b11-subunit in rats","volume":"26","author":"Nordquist","year":"2010","journal-title":"Diabetes Metabol. Res. Rev."},{"key":"10.1016\/j.ejmech.2024.116279_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116950","article-title":"The effect of C-peptide on diabetic nephropathy: a review of molecular mechanisms","volume":"237","author":"Yaribeygi","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2024.116279_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220779","article-title":"Synergistic effect of nano-selenium and metformin on type 2 diabetic rat model: diabetic complications alleviation through insulin sensitivity, oxidative mediators and inflammatory markers","volume":"14","author":"Abdulmalek","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2024.116279_bib66","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.2337\/diacare.26.5.1589","article-title":"New insights on oxidative stress and diabetic complications may lead to a \"causal\" antioxidant therapy","volume":"26","author":"Ceriello","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejmech.2024.116279_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e07363","article-title":"Antidiabetic and antihyperlipidemic effects of aqueous extract of Parquetina nigrescens in streptozotocin-nicotinamide induced type 2 diabetic rats","volume":"7","author":"Ojuade","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/j.ejmech.2024.116279_bib68","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jtcme.2019.06.005","article-title":"Antidiabetic activity of corn steep liquor extract of Curculigo pilosa and its solvent fractions in streptozotocin-induced diabetic rats","volume":"10","author":"Karigidi","year":"2020","journal-title":"J Tradit Complement Med"},{"key":"10.1016\/j.ejmech.2024.116279_bib69","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1177\/0192623308318209","article-title":"A review of islet of Langerhans degeneration in rodent models of type 2 diabetes","volume":"36","author":"Nugent","year":"2008","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ejmech.2024.116279_bib71","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ejmech.2015.04.033","article-title":"Synthesis, carbonic anhydrase inhibition and cytotoxic activity of novel chromone-based sulfonamide derivatives","volume":"96","author":"Awadallah","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib72","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/14756366.2018.1446432","article-title":"Inhibition studies on a panel of human carbonic anhydrases with N1-substituted secondary sulfonamides incorporating thiazolinone or imidazolone-indole tails","volume":"33","author":"Awadallah","year":"2018","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib73","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1007\/s11164-013-1488-2","article-title":"Design and synthesis of certain substituted cycloalkanecarboxamides structurally related to safinamide with anticonvulsant potential","volume":"41","author":"Aboul-Enein","year":"2015","journal-title":"Res. Chem. Intermed."},{"key":"10.1016\/j.ejmech.2024.116279_bib74","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0223-5234(96)88258-4","article-title":"Selective and potent monoamine oxidase type B inhibitors: substituted semicarbazones and acylhydrazones of aromatic aldehydes and ketones","volume":"30","author":"Bernard","year":"1995","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib75","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1002\/asia.201100154","article-title":"Isoxazol-5(4H)one derivatives as PTP1B inhibitors showing an anti-obesity effect","volume":"6","author":"Kafle","year":"2011","journal-title":"Chem. Asian J."},{"key":"10.1016\/j.ejmech.2024.116279_bib76","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1021\/jm00221a007","article-title":"Hypolipidemic analogs of ethyl 4-benzyloxybenzoate","volume":"20","author":"Baggaley","year":"1977","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib77","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.1016\/j.bmcl.2009.09.020","article-title":"Thiazolidinedione derivatives as PTP1B inhibitors with antihyperglycemic and antiobesity effects","volume":"19","author":"Bhattarai","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116279_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113097","article-title":"Discovery of highly potent and selective influenza virus neuraminidase inhibitors targeting 150-cavity","volume":"212","author":"Jia","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib79","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1021\/jm070352h","article-title":"Understanding the cardioprotective effects of flavonols: discovery of relaxant flavonols without antioxidant activity","volume":"51","author":"Qin","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib80","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1016\/j.bmcl.2016.10.013","article-title":"2-Phenylbenzo[b]furans: synthesis and promoting activity on estrogen biosynthesis","volume":"26","author":"Pu","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116279_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128804","article-title":"Synthesis, in vitro, in silico and in vivo hypoglycemic and lipid-lowering effects of 4-benzyloxy-5-benzylidene-1,3-thiazolidine-2,4-diones mediated by dual PPAR \u03b1\/\u03b3 modulation","volume":"70","author":"Madrigal-Angulo","year":"2022","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116279_bib82","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s13738-021-02381-y","article-title":"In vitro, in vivo and in silico-driven identification of novel benzimidazole derivatives as anticancer and anti-inflammatory agents","volume":"19","author":"Sathyanarayana","year":"2022","journal-title":"J. Iran. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.116279_bib83","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1016\/j.bmcl.2014.09.015","article-title":"Vanillin-derived antiproliferative compounds influence Plk1 activity","volume":"24","author":"Carrasco-Gomez","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116279_bib84","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1016\/j.bmcl.2014.10.092","article-title":"Discovery of novel 3-benzylquinazolin-4(3H)-ones as potent vasodilative agents","volume":"24","author":"Zuo","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116279_bib85","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200407","article-title":"Discovery of oxindole-based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation","volume":"356","author":"Bender","year":"2023","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2024.116279_bib86","doi-asserted-by":"crossref","first-page":"11860","DOI":"10.1021\/acs.jafc.9b03606","article-title":"First discovery of novel pyrido[1,2-a]pyrimidinone mesoionic compounds as antibacterial agents","volume":"67","author":"Liu","year":"2019","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib87","doi-asserted-by":"crossref","first-page":"10844","DOI":"10.1021\/jm300519w","volume":"55","author":"Cinelli","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib88","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1016\/j.bmc.2012.06.045","article-title":"Small molecules that protect against \u03b2-amyloid-induced cytotoxicity by inhibiting aggregation of \u03b2-amyloid","volume":"20","author":"Lee","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib89","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1021\/ol070781+","article-title":"Solid-supported acids as mild and versatile reagents for the deprotection of aromatic ethers","volume":"9","author":"Ploypradith","year":"2007","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2024.116279_bib90","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1021\/acs.jafc.7b01035","article-title":"Facile synthesis of novel vanillin derivatives incorporating a bis(2-hydroxyethyl)dithhioacetal moiety as antiviral agents","volume":"65","author":"Zhang","year":"2017","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib91","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1021\/jm980212v","article-title":"Design, synthesis, Structure\u2212Activity relationships, and biological characterization of novel arylalkoxyphenylalkylamine \u03c3 ligands as potential antipsychotic drugs","volume":"42","author":"Nakazato","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib92","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejmech.2013.11.001","article-title":"Synthesis, biological activity and structure\u2013activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells","volume":"71","author":"Ottan\u00e0","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib93","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1016\/j.bmcl.2014.07.063","article-title":"Repurposing human PDE4 inhibitors for neglected tropical diseases: design, synthesis and evaluation of cilomilast analogues as Trypanosoma brucei PDEB1 inhibitors","volume":"24","author":"Amata","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116279_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106504","article-title":"Anti-tyrosinase flavone derivatives and their anti-melanogenic activities: importance of the \u03b2-phenyl-\u03b1,\u03b2-unsaturated carbonyl scaffold","volume":"135","author":"Lee","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib95","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1016\/j.ejmech.2010.04.032","article-title":"Synthesis, antiproliferative activity and inhibition of tubulin polymerization by 1,5- and 1,8-disubstituted 10H-anthracen-9-ones bearing a 10-benzylidene or 10-(2-oxo-2-phenylethylidene) moiety","volume":"45","author":"Nickel","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib96","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.3390\/molecules26103034","article-title":"Design, synthesis, and evaluation of dihydropyranopyrazole derivatives as novel PDE2 inhibitors for the treatment of alzheimer's disease","volume":"26","author":"Zhou","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.116279_bib97","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejmech.2017.02.032","article-title":"Quinazoline derivatives as selective CYP1B1 inhibitors","volume":"130","author":"Mohd Siddique","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib98","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.cclet.2010.06.023","article-title":"Synthesis of 5-substituted benzyl-2,4-diamino pyrimidine derivatives as c-Fms kinase inhibitors","volume":"21","author":"Xu","year":"2010","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116279_bib99","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1016\/j.bmcl.2011.04.098","article-title":"Molecular hybridization of 4-azahexacyclo[5.4.1.02,6.03,10.05,9.08,11]dodecane-3-ol with sigma (\u03c3) receptor ligands modulates off-target activity and subtype selectivity","volume":"21","author":"Banister","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116279_bib100","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1063\/1.464913","article-title":"Density\u2010functional thermochemistry. III. The role of exact exchange","volume":"98","author":"Becke","year":"1993","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2024.116279_bib101","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00214-010-0846-z","article-title":"Minimally augmented Karlsruhe basis sets","volume":"128","author":"Zheng","year":"2011","journal-title":"Theor. Chem. Acc."},{"key":"10.1016\/j.ejmech.2024.116279_bib102","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.1021\/acs.chemrev.5b00533","article-title":"Dispersion-corrected mean-field electronic structure methods","volume":"116","author":"Grimme","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2024.116279_bib103","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/wcms.81","article-title":"The ORCA program system","volume":"2","author":"Neese","year":"2012","journal-title":"WIREs Comput Mol Sci"},{"key":"10.1016\/j.ejmech.2024.116279_bib104","doi-asserted-by":"crossref","DOI":"10.1002\/wcms.1606","article-title":"Software update: the ORCA program system\u2014version 5.0","volume":"12","author":"Neese","year":"2022","journal-title":"WIREs Comput Mol Sci"},{"key":"10.1016\/j.ejmech.2024.116279_bib105","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1186\/s12885-017-3578-9","article-title":"VEGFR2 regulates endothelial differentiation of colon cancer cells","volume":"17","author":"Liu","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejmech.2024.116279_bib106","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1292\/jvms.21-0478","article-title":"Sorafenib inhibits tumor cell growth and angiogenesis in canine transitional cell carcinoma","volume":"84","author":"Yokota","year":"2022","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.ejmech.2024.116279_bib107","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1017\/jns.2019.40","article-title":"Ficus deltoidea extract down-regulates protein tyrosine phosphatase 1B expression in a rat model of type 2 diabetes mellitus: a new insight into its antidiabetic mechanism","volume":"9","author":"Abdel-Rahman","year":"2020","journal-title":"J. Nutr. Sci."},{"key":"10.1016\/j.ejmech.2024.116279_bib108","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201700223","article-title":"Synthesis, docking, in vitro and in vivo antidiabetic activity of pyrazole-based 2,4-thiazolidinedione derivatives as PPAR-\u03b3 modulators","volume":"351","author":"Naim","year":"2018","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2024.116279_bib109","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1590\/S0100-879X2008005000030","article-title":"Parasympathetic dysfunction is associated with insulin resistance in fructose-fed female rats","volume":"41","author":"Brito","year":"2008","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.ejmech.2024.116279_bib110","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.862394","article-title":"Role of dapagliflozin and liraglutide on diabetes-induced cardiomyopathy in rats: implication of oxidative stress, inflammation, and apoptosis","volume":"13","author":"El-Shafey","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejmech.2024.116279_bib111","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/ajcp\/28.1.56","article-title":"A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases","volume":"28","author":"Reitman","year":"1957","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ejmech.2024.116279_bib112","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0021-9258(18)57021-6","article-title":"Determination of serum proteins by means of the biuret reaction","volume":"177","author":"Gornall","year":"1949","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib113","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0009-8981(72)90432-9","article-title":"[Serum creatinine determination without protein precipitation]","volume":"37","author":"Bartels","year":"1972","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejmech.2024.116279_bib114","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/jcp.13.2.156","article-title":"A rapid and precise method for the determination of urea","volume":"13","author":"Fawcett","year":"1960","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.ejmech.2024.116279_bib115","first-page":"882","article-title":"Improved method for the determination of blood glutathione","volume":"61","author":"Beutler","year":"1963","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.ejmech.2024.116279_bib116","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejmech.2024.116279_bib117","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","article-title":"Catalase in vitro","volume":"105","author":"Aebi","year":"1984","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejmech.2024.116279_bib118","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0076-6879(99)99005-5","article-title":"Ferric reducing\/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration","volume":"299","author":"Benzie","year":"1999","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejmech.2024.116279_bib119","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/clinchem\/20.4.470","article-title":"Enzymatic determination of total serum cholesterol","volume":"20","author":"Allain","year":"1974","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib120","first-page":"115","article-title":"Liquid triglycerides (GPO-PAP). Medi diagnostic Italy","volume":"9","author":"Annoni","year":"1982","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.ejmech.2024.116279_bib121","series-title":"Bancroft's Theory and Practice of Histological Techniques","author":"Bancroft","year":"2013"},{"key":"10.1016\/j.ejmech.2024.116279_bib122","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.ejmech.2024.116279_bib123","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/prot.22711","article-title":"Improved side-chain torsion potentials for the Amber ff99SB protein force field","volume":"78","author":"Lindorff-Larsen","year":"2010","journal-title":"Proteins"},{"key":"10.1016\/j.ejmech.2024.116279_bib124","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib125","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","article-title":"Automatic atom type and bond type perception in molecular mechanical calculations","volume":"25","author":"Wang","year":"2006","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.ejmech.2024.116279_bib126","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/1756-0500-5-367","article-title":"Acpype - AnteChamber PYthon parser interfacE","volume":"5","author":"Sousa da Silva","year":"2012","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.ejmech.2024.116279_bib127","doi-asserted-by":"crossref","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2024.116279_bib128","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2024.116279_bib129","doi-asserted-by":"crossref","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: a linear Constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2024.116279_bib130","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: a new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J. Appl. Phys."},{"key":"10.1016\/j.ejmech.2024.116279_bib131","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N\u22c5log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2024.116279_bib132","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1529\/biophysj.105.066654","article-title":"Gaussian-weighted RMSD superposition of proteins: a structural comparison for flexible proteins and predicted protein structures","volume":"90","author":"Damm","year":"2006","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejmech.2024.116279_bib133","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1006\/jmbi.1994.1017","article-title":"Significance of root-mean-square deviation in comparing three-dimensional structures of globular proteins","volume":"235","author":"Maiorov","year":"1994","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejmech.2024.116279_bib134","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1093\/bioinformatics\/bts445","article-title":"Measuring and comparing structural fluctuation patterns in large protein datasets","volume":"28","author":"Fuglebakk","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejmech.2024.116279_bib135","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1134\/S0026893308040195","article-title":"Radius of gyration as an indicator of protein structure compactness","volume":"42","author":"Lobanov","year":"2008","journal-title":"Mol. Biol."},{"key":"10.1016\/j.ejmech.2024.116279_bib136","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424001594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424001594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:58:39Z","timestamp":1759330719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424001594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":135,"alternative-id":["S0223523424001594"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116279","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel thiazolidin-4-one benzenesulfonamide hybrids as PPAR\u03b3 agonists: Design, synthesis and in vivo anti-diabetic evaluation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116279","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116279"}}